{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06319820",
            "orgStudyIdInfo": {
                "id": "42756493BLC3004"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-507684-19",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Janssen Research & Development, LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer",
            "officialTitle": "A Phase 3, Randomized Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Single Agent Intravesical Chemotherapy in Participants With Intermediate-risk Non-muscle Invasive Bladder Cancer (IR-NMIBC) and Susceptible FGFR Alterations",
            "acronym": "MoonRISe-1",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-to-evaluate-tar-versus-single-agent-intravesical-cancer-treatment-in-participants-with-bladder-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-06-28",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-06-28",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-13",
            "studyFirstSubmitQcDate": "2024-03-13",
            "studyFirstPostDateStruct": {
                "date": "2024-03-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-16",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-18",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Janssen Research & Development, LLC",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's choice of intravesical chemotherapy for treatment of intermediate-risk NMIBC."
        },
        "conditionsModule": {
            "conditions": [
                "Non-Muscle Invasive Bladder Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 540,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Group A: TAR-210",
                    "type": "EXPERIMENTAL",
                    "description": "Participants in Group A will have TAR-210 inserted in the bladder on Day 1 and removed after 12 weeks. One TAR-210 will be inserted every 12 weeks over a treatment period of approximately 1 year.",
                    "interventionNames": [
                        "Combination Product: TAR-210"
                    ]
                },
                {
                    "label": "Group B: MMC or Gemcitabine",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants in Group B will receive intravesical mitomycin C (MMC) or gemcitabine (investigator's choice) once weekly for 4 to 6 induction doses followed by a maintenance phase for a minimum of 6 months and up to 1 year.",
                    "interventionNames": [
                        "Drug: Gemcitabine",
                        "Drug: MMC"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "TAR-210",
                    "description": "TAR-210 will be administered intravesically.",
                    "armGroupLabels": [
                        "Group A: TAR-210"
                    ],
                    "otherNames": [
                        "JNJ-42756493"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Gemcitabine",
                    "description": "Gemcitabine will be administered intravesically.",
                    "armGroupLabels": [
                        "Group B: MMC or Gemcitabine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "MMC",
                    "description": "MMC will be administered intravesically.",
                    "armGroupLabels": [
                        "Group B: MMC or Gemcitabine"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Disease Free Survival (DFS)",
                    "description": "DFS is measured as the time from randomization to the date of the first documented recurrence of non-muscle invasive bladder cancer (NMIBC) of any grade, disease progression, or death due to any cause, whichever occurs first.",
                    "timeFrame": "From randomization to the date of the first documented recurrence, disease progression or death (approximately 4 years and 2 months)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Time to next Treatment (TTNT)",
                    "description": "TTNT is measured as the time from randomization to the date of first documented subsequent treatment (local, systemic, surgical, or interventional) for bladder cancer.",
                    "timeFrame": "From randomization to the date of first documented subsequent treatment (local, systemic, surgical, or interventional) for bladder cancer (approximately 4 years and 2 months)"
                },
                {
                    "measure": "High Grade Recurrence-free Survival (HG RFS)",
                    "description": "HG RFS is measured as the time from randomization to the date of first documented evidence of HG NMIBC or death, whichever occurs first",
                    "timeFrame": "From randomization to the date of first documented evidence of HG NMIBC or death (approximately 4 years and 2 months)"
                },
                {
                    "measure": "Progression Free Survival (PFS)",
                    "description": "PFS is measured as the time from randomization to the date of first documented evidence of disease progression or death, whichever occurs first.",
                    "timeFrame": "From randomization to the date of first documented disease progression or death (approximately 4 years and 2 months)"
                },
                {
                    "measure": "Rate of Diagnostic and Therapeutic Invasive Urological Interventions after Study Treatment",
                    "description": "Rate of diagnostic and therapeutic invasive urological interventions after study treatment, that is, endoscopic procedures (e.g., cystoscopies, transurethral resection of bladder tumors (TURBTs), ureteroscopies, urethral interventions, urethral stricture/bladder neck incision), catheterization (intravesical, suprapubic), intravesical treatments, major surgeries (e.g., radical cystectomy, simple cystectomy, urethroplasty) will be reported.",
                    "timeFrame": "From study treatment completion up to trial discontinuation (approximately 4 years and 2 months)"
                },
                {
                    "measure": "Number of Participants With Adverse Events (Including Physical Examination, Vital Signs and Laboratory Abnormalities)",
                    "description": "An AE is any untoward medical occurrence in a participant participating in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product, that does not necessarily have a causal relationship with the treatment. AEs will be evaluated according to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) Version 5.0. Severity of AEs has 5 grades based on CTCAE criteria: Grade 1: Mild; Grade 2: Moderate; Grade 3: Severe; Grade 4: Life-threatening and Grade 5: Death. Number of participants with adverse events (including physical examination, vital signs and laboratory abnormalities) will be reported.",
                    "timeFrame": "From first dose up to 30 days after last dose of study treatment (approximately 4 years and 2 months)"
                },
                {
                    "measure": "Overall Survival (OS)",
                    "description": "OS is defined as the time from randomization to the date of death from any cause.",
                    "timeFrame": "From randomization to the date of death (approximately 4 years and 2 months)"
                },
                {
                    "measure": "European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire Core-30 items (EORTC-QLQ-C30) Scores",
                    "description": "EORTC QLQ-C30 is a core 30-item questionnaire for evaluating the health-related quality of life (HRQoL) of participants participating in cancer clinical studies. It incorporates 5 functional scales (physical, role, cognitive, emotional, and social functioning), 3 symptom scales (fatigue, pain, and nausea or vomiting), and a global health status or HRQoL scale. Ratings for each item range from 1 (not at all) to 4 (very much). Higher scores indicated greater severity.",
                    "timeFrame": "Baseline, Weeks 6, 12, 24, 36, and 48"
                },
                {
                    "measure": "European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire for Non muscle Invasive Bladder Cancer (EORTC-QLQ-NMIBC24) Scores",
                    "description": "EORTC QLQ-NMIBC24 is a 24-item questionnaire for evaluating the HRQoL of participants with non-muscle-invasive bladder cancer. The questionnaire is designed to supplement the QLQ C30 and incorporates 6 multi-item scales and 5 single items. Ratings for each item range from 1 (not at all) to 4 (very much). Higher scores indicated greater severity.",
                    "timeFrame": "Baseline, Weeks 6, 12, 24, 36, and 48"
                },
                {
                    "measure": "Percentage of Participants With Significant Change From Baseline in EORTC-QLQ-C30 Scores",
                    "description": "EORTC QLQ-C30 is a core 30-item questionnaire for evaluating the HRQoL of participants participating in cancer clinical studies. It incorporates 5 functional scales (physical, role, cognitive, emotional, and social functioning), 3 symptom scales (fatigue, pain, and nausea or vomiting), and a global health status or HRQoL scale. Ratings for each item range from 1 (not at all) to 4 (very much). Higher scores indicated greater severity.",
                    "timeFrame": "Weeks 6, 12, 24, 36, and 48"
                },
                {
                    "measure": "Percentage of Participants With Significant Change From Baseline in EORTC-QLQ-NMIBC24 Scores",
                    "description": "EORTC QLQ-NMIBC24 is a 24-item questionnaire for evaluating the HRQoL of participants with non-muscle-invasive bladder cancer. The questionnaire is designed to supplement the QLQ C30 and incorporates 6 multi-item scales and 5 single items. Ratings for each item range from 1 (not at all) to 4 (very much). Higher scores indicated greater severity.",
                    "timeFrame": "Weeks 6, 12, 24, 36, and 48"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Have a susceptible fibroblast growth factor receptor (FGFR) mutation or fusion either by urine testing or tumor tissue testing (from TURBT tissue), as determined by central or local testing\n* Participants must be willing to undergo all study procedures (e.g., multiple cystoscopies from Screening through the end of study and TURBT for assessment of recurrence/progression) and receive the assigned treatment, including intravesical chemotherapy if randomized into that arm.\n* Visible papillary disease must be fully resected prior to randomization and absence of disease must be documented at Screening cystoscopy. The same method for visualizing disease at Screening cystoscopy should be used throughout for the participant (white light versus enhanced assessment method)\n* Can have a prior or concurrent second malignancy (other than the disease under study) which natural history or treatment is unlikely to interfere with any study endpoints of safety or the efficacy of the study treatment\n* Have an Eastern Cooperative Oncology Group performance status of 0 to 2\n\nExclusion Criteria:\n\n* Known allergies, hypersensitivity, or intolerance to any study component or its excipients, including: a. Erdafitinib excipients; b.TAR-210 drug delivery system constituent materials ; c. urinary placement catheter materials; d. MMC or chemically related drugs; e. Gemcitabine or chemically related drugs\n* Presence of any bladder or urethral anatomic feature (that is, urethral stricture) that, in the opinion of the investigator, may prevent the safe insertion, indwelling use, removal of TAR-210 or passage of a urethral catheter for intravesical chemotherapy\n* Polyuria with recorded 24-hour urine volumes greater than (\\>) 4000 mL\n* Current indwelling urinary catheters, however, intermittent catheterization is acceptable\n* Had major surgery or had significant traumatic injury and/or not fully recovered within 4 weeks before first dose (TURBT is not considered major surgery)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Study Contact",
                    "role": "CONTACT",
                    "phone": "844-434-4210",
                    "email": "Participate-In-This-Study@its.jnj.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Johnson & Johnson Enterprise Innovation Inc. Clinical Trial",
                    "affiliation": "Johnson & Johnson Enterprise Innovation Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Arkansas Urology",
                    "status": "RECRUITING",
                    "city": "Little Rock",
                    "state": "Arkansas",
                    "zip": "72211",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.74648,
                        "lon": -92.28959
                    }
                },
                {
                    "facility": "Genesis Research LLC",
                    "status": "RECRUITING",
                    "city": "Los Alamitos",
                    "state": "California",
                    "zip": "90720",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.80307,
                        "lon": -118.07256
                    }
                },
                {
                    "facility": "Genesis Research",
                    "status": "RECRUITING",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92123",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "Genesis Research LLC",
                    "status": "RECRUITING",
                    "city": "Sherman Oaks",
                    "state": "California",
                    "zip": "91411",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.15112,
                        "lon": -118.44925
                    }
                },
                {
                    "facility": "Colorado Clinical Research",
                    "status": "RECRUITING",
                    "city": "Lakewood",
                    "state": "Colorado",
                    "zip": "80228",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.70471,
                        "lon": -105.08137
                    }
                },
                {
                    "facility": "First Urology",
                    "status": "RECRUITING",
                    "city": "Jeffersonville",
                    "state": "Indiana",
                    "zip": "47130",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.27757,
                        "lon": -85.73718
                    }
                },
                {
                    "facility": "Chesapeake Urology Research Associates",
                    "status": "RECRUITING",
                    "city": "Hanover",
                    "state": "Maryland",
                    "zip": "21076",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.19289,
                        "lon": -76.72414
                    }
                },
                {
                    "facility": "Comprehensive Urology",
                    "status": "RECRUITING",
                    "city": "Royal Oak",
                    "state": "Michigan",
                    "zip": "48073",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.48948,
                        "lon": -83.14465
                    }
                },
                {
                    "facility": "Specialty Clinical Research of St Louis",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63141",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Cancer Institute Of New Jersey",
                    "status": "RECRUITING",
                    "city": "New Brunswick",
                    "state": "New Jersey",
                    "zip": "08901",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.48622,
                        "lon": -74.45182
                    }
                },
                {
                    "facility": "Integrated Medical Professionals",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10016",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Associated Medical Professionals of Ny",
                    "status": "RECRUITING",
                    "city": "Syracuse",
                    "state": "New York",
                    "zip": "13210",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 43.04812,
                        "lon": -76.14742
                    }
                },
                {
                    "facility": "Associated Urologists of North Carolina",
                    "status": "RECRUITING",
                    "city": "Raleigh",
                    "state": "North Carolina",
                    "zip": "27612",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.7721,
                        "lon": -78.63861
                    }
                },
                {
                    "facility": "MidLantic Urology",
                    "status": "RECRUITING",
                    "city": "Bala-Cynwyd",
                    "state": "Pennsylvania",
                    "zip": "19004",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.00761,
                        "lon": -75.23407
                    }
                },
                {
                    "facility": "Keystone Urology Specialists",
                    "status": "RECRUITING",
                    "city": "Lancaster",
                    "state": "Pennsylvania",
                    "zip": "17604",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.03788,
                        "lon": -76.30551
                    }
                },
                {
                    "facility": "Carolina Urologic Research Center",
                    "status": "RECRUITING",
                    "city": "Myrtle Beach",
                    "state": "South Carolina",
                    "zip": "29572",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.68906,
                        "lon": -78.88669
                    }
                },
                {
                    "facility": "The Conrad Pearson Clinic",
                    "status": "RECRUITING",
                    "city": "Germantown",
                    "state": "Tennessee",
                    "zip": "38138",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.08676,
                        "lon": -89.81009
                    }
                },
                {
                    "facility": "Urology Associates",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37209",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "Urology Austin",
                    "status": "RECRUITING",
                    "city": "Austin",
                    "state": "Texas",
                    "zip": "78745",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.26715,
                        "lon": -97.74306
                    }
                },
                {
                    "facility": "Urology Clinics of North Texas",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75231",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Houston Metro Urology",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77027",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Spokane Urology",
                    "status": "RECRUITING",
                    "city": "Spokane",
                    "state": "Washington",
                    "zip": "99202",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.65966,
                        "lon": -117.42908
                    }
                },
                {
                    "facility": "Investigaciones Clinico Moleculares (ICM)",
                    "status": "RECRUITING",
                    "city": "Caba",
                    "zip": "C1425",
                    "country": "Argentina",
                    "geoPoint": {
                        "lat": -34.61315,
                        "lon": -58.37723
                    }
                },
                {
                    "facility": "Hospital Sirio Libanes",
                    "status": "RECRUITING",
                    "city": "Ciudad Autonoma de Buenos Aires",
                    "zip": "C1419AHN",
                    "country": "Argentina",
                    "geoPoint": {
                        "lat": -34.61315,
                        "lon": -58.37723
                    }
                },
                {
                    "facility": "Centro Urologico Profesor Bengio",
                    "status": "RECRUITING",
                    "city": "C\u00f3rdoba",
                    "zip": "X5000KPH",
                    "country": "Argentina",
                    "geoPoint": {
                        "lat": -31.4135,
                        "lon": -64.18105
                    }
                },
                {
                    "facility": "Vitaz",
                    "status": "RECRUITING",
                    "city": "Sint-Niklaas",
                    "zip": "9100",
                    "country": "Belgium",
                    "geoPoint": {
                        "lat": 51.16509,
                        "lon": 4.1437
                    }
                },
                {
                    "facility": "Prince Of Wales Hospital",
                    "status": "RECRUITING",
                    "city": "Hong Kong",
                    "country": "Hong Kong",
                    "geoPoint": {
                        "lat": 22.27832,
                        "lon": 114.17469
                    }
                },
                {
                    "facility": "Queen Mary Hospital",
                    "status": "RECRUITING",
                    "city": "Hong Kong",
                    "country": "Hong Kong",
                    "geoPoint": {
                        "lat": 22.27832,
                        "lon": 114.17469
                    }
                },
                {
                    "facility": "Rambam Health Care Campus",
                    "status": "RECRUITING",
                    "city": "Haifa",
                    "zip": "3109601",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.81841,
                        "lon": 34.9885
                    }
                },
                {
                    "facility": "Hadassah University Hospita Ein Kerem",
                    "status": "RECRUITING",
                    "city": "Jerusalem",
                    "zip": "9112001",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 31.76904,
                        "lon": 35.21633
                    }
                },
                {
                    "facility": "Ziv Medical Center",
                    "status": "RECRUITING",
                    "city": "Safed",
                    "zip": "13100",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.96465,
                        "lon": 35.496
                    }
                },
                {
                    "facility": "Sourasky Medical Center",
                    "status": "RECRUITING",
                    "city": "Tel-Aviv",
                    "zip": "6423906",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.08088,
                        "lon": 34.78057
                    }
                },
                {
                    "facility": "St Marianna University Hospital",
                    "status": "RECRUITING",
                    "city": "Kawasaki Shi",
                    "zip": "216 8511",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.52056,
                        "lon": 139.71722
                    }
                },
                {
                    "facility": "JRC Wakayama Medical Center",
                    "status": "RECRUITING",
                    "city": "Wakayama",
                    "zip": "640 8558",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.23333,
                        "lon": 135.16667
                    }
                },
                {
                    "facility": "Yokohama Municipal Citizens Hospital",
                    "status": "RECRUITING",
                    "city": "Yokohama",
                    "zip": "221 0855",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.43333,
                        "lon": 139.65
                    }
                },
                {
                    "facility": "Yokohama City University Medical Center",
                    "status": "RECRUITING",
                    "city": "Yokohama",
                    "zip": "232 0024",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.43333,
                        "lon": 139.65
                    }
                },
                {
                    "facility": "Yokosuka Kyosai Hospital",
                    "status": "RECRUITING",
                    "city": "Yokosuka",
                    "zip": "238 8558",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.28361,
                        "lon": 139.66722
                    }
                },
                {
                    "facility": "Chonnam National University Hwasun Hospital",
                    "status": "RECRUITING",
                    "city": "Jeollanam-do",
                    "zip": "58128",
                    "country": "Korea, Republic of"
                },
                {
                    "facility": "Samsung Medical Center",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "06351",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Uniwersytecki Szpital Kliniczny w Bialymstoku",
                    "status": "RECRUITING",
                    "city": "Bialystok",
                    "zip": "15-276",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 53.13333,
                        "lon": 23.16433
                    }
                },
                {
                    "facility": "IN VIVO Sp. z o.o",
                    "status": "RECRUITING",
                    "city": "Bydgoszcz",
                    "zip": "85-048",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 53.1235,
                        "lon": 18.00762
                    }
                },
                {
                    "facility": "Szpital Wojewodzki Im Sw Lukasza Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Tarnowie",
                    "status": "RECRUITING",
                    "city": "Tarnow",
                    "zip": "33-100",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 50.01381,
                        "lon": 20.98698
                    }
                },
                {
                    "facility": "Hosp. Univ. 12 de Octubre",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28041",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "St Bartholomews Hospital",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "EC1A 7BE",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Charing Cross Hospital",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "W6 8RF",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Royal Marsden Hospital",
                    "status": "RECRUITING",
                    "city": "Sutton",
                    "zip": "SM2 5PT",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.35,
                        "lon": -0.2
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "The data sharing policy of the Janssen Pharmaceutical Companies of Johnson \\& Johnson is available at www.janssen.com/clinical-trials/transparency. As noted on this site, requests for access to the study data can be submitted through Yale open Data Access (YODA) Project site at yoda.yale.edu",
            "url": "http://www.janssen.com/clinical-trials/transparency"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "removedCountries": [
                "Czechia"
            ]
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001749",
                    "term": "Urinary Bladder Neoplasms"
                },
                {
                    "id": "D000093284",
                    "term": "Non-Muscle Invasive Bladder Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014571",
                    "term": "Urologic Neoplasms"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000001745",
                    "term": "Urinary Bladder Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5030",
                    "name": "Urinary Bladder Neoplasms",
                    "asFound": "Bladder Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2976",
                    "name": "Non-Muscle Invasive Bladder Neoplasms",
                    "asFound": "Non-muscle Invasive Bladder Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17320",
                    "name": "Urologic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M5026",
                    "name": "Urinary Bladder Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000093542",
                    "term": "Gemcitabine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000964",
                    "term": "Antimetabolites, Antineoplastic"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M2985",
                    "name": "Gemcitabine",
                    "asFound": "Mg/kg",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11903",
                    "name": "Mitomycins",
                    "relevance": "LOW"
                },
                {
                    "id": "M19053",
                    "name": "Mitomycin",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}